-The United Nations   The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS. The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive...

-The United Nations   The United Nations agency mandated to spearhead the global response to HIV/AIDS today welcomed the new license agreement between the Medicines Patent Pool and the pharmaceutical company Gilead Sciences to increase access to antiretroviral therapy in developing countries. The Joint UN Programme on HIV/AIDS (UNAIDS) said the agreement marks the first time a pharmaceutical company has signed an agreement with the Medicines Patent Pool, describing it as a turning...

While ‘data exclusivity’ clauses will not feature in the India-European Union free trade agreement (FTA), the threat posed by the impending deal to the world’s supply of cheap generic drugs is far from over. India’s commerce and industry minister Anand Sharma assured Michel Sidibe, chief of the United Nations joint programme on HIV and AIDS (UNAIDS) at a meeting this week that India would reject attempts by pharmaceutical giants to include...

-PTI   To step in to prevent “more Nandigrams” The Supreme Court on Monday criticised the Uttar Pradesh government for acquiring prime agricultural land to build luxury flats in Greater Noida and questioned the invoking of an urgency clause that bars farmers from raising objections. It noted it would step in to prevent “more Nandigrams.” “Whose residential use are these flats for? Who is building them? What are the prices? We want to...

Poor Andhra villagers now victims of clinical drug trials No Drug Resistance     * 35 women, some men from Guntur district put throughclinical trials of a breast cancer drug. They later complain of joint pains, nausea and chest pains.     * Biotech industry in Andhra is worth about Rs 455 crore     * Touts operating on behalf of pharma companies get people from the poorer districts to Hyderabad for the tests *** Some 35 women...